Boothbay Fund Management, LLC Cue Biopharma, Inc. Transaction History
Boothbay Fund Management, LLC
- $5.7 Billion
- Q3 2025
A detailed history of Boothbay Fund Management, LLC transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 610,964 shares of CUE stock, worth $384,907. This represents 0.01% of its overall portfolio holdings.
Number of Shares
610,964Holding current value
$384,907% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding CUE
# of Institutions
53Shares Held
18.4MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.3 Million1.28% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.43MShares$2.16 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$1.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA801KShares$504,4830.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$476,7430.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $22.3M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...